Table 1.
Immunostaining positive cells* | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Biopsy after onset | Lymphocyte infiltrating | Plasma cell * | T cell | Plasma cells | B cells | Macrophages | Remarkst † | |||||
Case | Age | Sex | RF | (months) | patterns | (H&E) | (CD3) | (CD38) | (CD138) | (CD20) | (CD68) | (theraph, etc.) |
1 | 50 | F | + | 2 | Diffuse | − | + | + | − | − | + + | NSAIDs |
2 | 34 | F | − | 4 | Diffuse | + | + | + | − | − | + | NSAIDs |
3 | 34 | F | + | 3 | Diffuse | + + | + + | + + | + + | + | + + + | NSAIDs |
4 | 77 | F | − | 2 | Diffuse+ aggregate | + + | + + + | + + | + | + | + + + | NSAIDs |
5 | 50 | M | − | 4 | Diffuse | + + | + | + + | − | + | + | |
6 | 37 | F | + | 7 | Diffuse | + | + | + + | − | + | + | |
7 | 61 | F | − | 2 | Diffuse | + | + | + + | + | + | + + | PSL (5 mg) |
8 | 25 | F | − | 12 | Diffuse | + + + | + | + | + + + | + + | + + | NSAIDs |
9 | 60 | F | + | 4 | Diffuse+ aggregate | + + + | + | + + + | + + + | + + + | + + | NSAIDs |
Relative amounts of infiltrating cells of lymphocyte subsets and macrophages between the cases examined were scored; −; none, + ; mild, + + ; moderate, and + + + ; severe.
NSAIDs; non-steridal anti-inflammatory drugs, PSL; prednisolone.